Retroscreen Virology Limited, a global leader in anti-viral research, clinical trials and experimental challenge studies, is pleased to announce that Dr Rob Lambkin-Williams, Chief Executive Officer, will be chairing a key session at the forthcoming “Influenza USA 2010” conference. This conference will be held at the Hilton Embassy Row, Washington DC, from 8-10 November 2010, and will feature a session covering “Next Generation Vaccine Technologies” during which Dr Lambkin-Williams will chair the panel session on “Advancements in Non-Egg Based Vaccines”.

This is an annual conference that brings together scientists working on all aspects of influenza, from basic science to healthcare policy. Influenza is the fastest growing segment in the adult vaccine market and is a key research area for Retroscreen, with Dr Lambkin-Williams being a recognised expert in the field.

For further information on the conference, please visit: www.terrapinn.com/2010/usaflu